Loading clinical trials...
Loading clinical trials...
Prospective, Multi-center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas
Conditions
Interventions
lenalidomide
etoposide
+7 more
Locations
6
United States
Rush University Medical Center
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
NorthShore University HealthSystem
Evanston, Illinois, United States
Illinois Cancer Care
Peoria, Illinois, United States
University of Maryland
Baltimore, Maryland, United States
Start Date
July 29, 2014
Primary Completion Date
October 1, 2024
Completion Date
October 29, 2024
Last Updated
March 11, 2026
NCT01815749
NCT01769222
NCT01523223
NCT00536601
NCT00089011
NCT01326702
Lead Sponsor
University of Chicago
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions